Skip to content

Effectiveness of Pain Neuroscience Education Along With Neural Mobilization Versus Neural Mobilization Alone on Pain, Functional Disability And Quality of Life In Patients With Diabetic Neuropathic Pain

Effectiveness of Pain Neuroscience Education Along With Neural Mobilization Versus Neural Mobilization Alone on Pain, Functional Disability And Quality of Life In Patients With Diabetic Neuropathic Pain

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07695181
Enrollment
40
Registered
2026-07-10
Start date
2026-07-10
Completion date
2027-01-20
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Neuropathic Pain

Brief summary

This is a randomized controlled trial aims to evaluate the comparative effect of Pain Neuroscience Education combined with neural mobilization versus neural mobilization alone in patients with diabetic neuropathic pain. This study will Compare pain intensity between intervention groups and assess functional disability outcomes. Furthermore, this will evaluate changes in quality of life and to analyze pain-related beliefs following PNE.

Interventions

OTHERPain Neurosciences Education + Neural Mobilization

In Group A pain neuroscience Education will be given in adjunct with neural mobilization techniques Target nerves: Sciatic, tibial \& common peroneal Technique: Slider neurodynamic mobilization Dosage: 10-15 reps × 2-3 sets \| Rest: 30-60 sec between sets Session duration: 15-20 minutes PNE: 20-30 min (weeks 1-2) → 10 min reinforcement (weeks 3-6) Methods: Simple diagrams, patient-friendly metaphors, video demonstrations

Sponsors

Ibadat International University, Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

2 parallel group; Group A - PNE + Neural Mobilization and Group B - Neural Mobilization Alone

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age ≥ 40 years (WHO 2016 criteria) Diagnosed Type II diabetes mellitus Lower limb neuropathic pain ≥ 3 months Pain intensity ≥ 4/10 on NPRS Able to walk independently and follow instructions

Exclusion criteria

Neurological disorders (e.g. stroke, Guillain-Barré) Lumbar disc herniation with radiculopathy Lower limb surgery or spinal fracture within 6 months Active diabetic foot ulcer Diagnosed cognitive impairment or severe infection

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityBaseline to week 6Pain intensity will be evaluated using Numeric Pain Rating Scale
Functional disabilityBaseline to week 6Functional disability will be evaluated using Urdu version of Lower Extremity Functional Scale (LEFS)
Quality of lifeBaseline to week 6Quality of life will be evaluated by World Health Organization Quality Of Life-BREF
Central sensitizationBaseline to week 6Central sensitization will be evaluated using Central Sensitization Inventory

Countries

Pakistan

Contacts

CONTACTRoshan Farman, MSPT
5012324032@student.iiui.edu.pk+923188108470
CONTACTSomiya Naz, PhD scholar
somiyanaz@uipt.iiui.edu.pk+923315163093

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026